Immunopathology of Chronic Hepatitis B Infection: Role of Innate and Adaptive Immune Response in Disease Progression

More than 250 million people are living with chronic hepatitis B despite the availability of highly effective vaccines and oral antivirals. Although innate and adaptive immune cells play crucial roles in controlling hepatitis B virus (HBV) infection, they are also accountable for inflammation and su...

Full description

Bibliographic Details
Main Authors: Arshi Khanam, Joel V. Chua, Shyam Kottilil
Format: Article
Language:English
Published: MDPI AG 2021-05-01
Series:International Journal of Molecular Sciences
Subjects:
Online Access:https://www.mdpi.com/1422-0067/22/11/5497
_version_ 1797533021440573440
author Arshi Khanam
Joel V. Chua
Shyam Kottilil
author_facet Arshi Khanam
Joel V. Chua
Shyam Kottilil
author_sort Arshi Khanam
collection DOAJ
description More than 250 million people are living with chronic hepatitis B despite the availability of highly effective vaccines and oral antivirals. Although innate and adaptive immune cells play crucial roles in controlling hepatitis B virus (HBV) infection, they are also accountable for inflammation and subsequently cause liver pathologies. During the initial phase of HBV infection, innate immunity is triggered leading to antiviral cytokines production, followed by activation and intrahepatic recruitment of the adaptive immune system resulting in successful virus elimination. In chronic HBV infection, significant alterations in both innate and adaptive immunity including expansion of regulatory cells, overexpression of co-inhibitory receptors, presence of abundant inflammatory mediators, and modifications in immune cell derived exosome release and function occurs, which overpower antiviral response leading to persistent viral infection and subsequent immune pathologies associated with disease progression towards fibrosis, cirrhosis, and hepatocellular carcinoma. In this review, we discuss the current knowledge of innate and adaptive immune cells transformations that are associated with immunopathogenesis and disease outcome in CHB patients.
first_indexed 2024-03-10T11:08:41Z
format Article
id doaj.art-c61de352fe944772aef42364e24bb84e
institution Directory Open Access Journal
issn 1661-6596
1422-0067
language English
last_indexed 2024-03-10T11:08:41Z
publishDate 2021-05-01
publisher MDPI AG
record_format Article
series International Journal of Molecular Sciences
spelling doaj.art-c61de352fe944772aef42364e24bb84e2023-11-21T21:00:43ZengMDPI AGInternational Journal of Molecular Sciences1661-65961422-00672021-05-012211549710.3390/ijms22115497Immunopathology of Chronic Hepatitis B Infection: Role of Innate and Adaptive Immune Response in Disease ProgressionArshi Khanam0Joel V. Chua1Shyam Kottilil2Division of Clinical Care and Research, Institute of Human Virology, University of Maryland School of Medicine, Baltimore, MD 21201, USADivision of Clinical Care and Research, Institute of Human Virology, University of Maryland School of Medicine, Baltimore, MD 21201, USADivision of Clinical Care and Research, Institute of Human Virology, University of Maryland School of Medicine, Baltimore, MD 21201, USAMore than 250 million people are living with chronic hepatitis B despite the availability of highly effective vaccines and oral antivirals. Although innate and adaptive immune cells play crucial roles in controlling hepatitis B virus (HBV) infection, they are also accountable for inflammation and subsequently cause liver pathologies. During the initial phase of HBV infection, innate immunity is triggered leading to antiviral cytokines production, followed by activation and intrahepatic recruitment of the adaptive immune system resulting in successful virus elimination. In chronic HBV infection, significant alterations in both innate and adaptive immunity including expansion of regulatory cells, overexpression of co-inhibitory receptors, presence of abundant inflammatory mediators, and modifications in immune cell derived exosome release and function occurs, which overpower antiviral response leading to persistent viral infection and subsequent immune pathologies associated with disease progression towards fibrosis, cirrhosis, and hepatocellular carcinoma. In this review, we discuss the current knowledge of innate and adaptive immune cells transformations that are associated with immunopathogenesis and disease outcome in CHB patients.https://www.mdpi.com/1422-0067/22/11/5497CHBinnate immune cellsadaptive immune cellsinflammation
spellingShingle Arshi Khanam
Joel V. Chua
Shyam Kottilil
Immunopathology of Chronic Hepatitis B Infection: Role of Innate and Adaptive Immune Response in Disease Progression
International Journal of Molecular Sciences
CHB
innate immune cells
adaptive immune cells
inflammation
title Immunopathology of Chronic Hepatitis B Infection: Role of Innate and Adaptive Immune Response in Disease Progression
title_full Immunopathology of Chronic Hepatitis B Infection: Role of Innate and Adaptive Immune Response in Disease Progression
title_fullStr Immunopathology of Chronic Hepatitis B Infection: Role of Innate and Adaptive Immune Response in Disease Progression
title_full_unstemmed Immunopathology of Chronic Hepatitis B Infection: Role of Innate and Adaptive Immune Response in Disease Progression
title_short Immunopathology of Chronic Hepatitis B Infection: Role of Innate and Adaptive Immune Response in Disease Progression
title_sort immunopathology of chronic hepatitis b infection role of innate and adaptive immune response in disease progression
topic CHB
innate immune cells
adaptive immune cells
inflammation
url https://www.mdpi.com/1422-0067/22/11/5497
work_keys_str_mv AT arshikhanam immunopathologyofchronichepatitisbinfectionroleofinnateandadaptiveimmuneresponseindiseaseprogression
AT joelvchua immunopathologyofchronichepatitisbinfectionroleofinnateandadaptiveimmuneresponseindiseaseprogression
AT shyamkottilil immunopathologyofchronichepatitisbinfectionroleofinnateandadaptiveimmuneresponseindiseaseprogression